Related Experiment Video
Updated: Jun 18, 2026

Lipidomics and Transcriptomics in Neurological Diseases
Published on: March 18, 2022
Neurologic presentations of hepatic disease
Meghan K Harris1, Debra Elliott, Robert N Schwendimann
1Department of Neurology, Louisiana State University Health Sciences Center, 1501 Kings Highway, Shreveport, LA 71130, USA.
Hepatic encephalopathy (HE) is a reversible brain condition linked to liver disease and blood shunting. Recent research offers new insights into its causes, diagnosis, and treatment strategies.
Area of Science:
- Neuroscience
- Hepatology
- Internal Medicine
Background:
- Hepatic encephalopathy (HE) is a neuropsychiatric syndrome associated with liver dysfunction and portosystemic shunting.
- It presents with altered consciousness and various neurological symptoms.
- The exact mechanisms causing brain dysfunction in HE are still under investigation.
Purpose of the Study:
- To review recent advancements in understanding the pathophysiology of hepatic encephalopathy.
- To discuss current diagnostic approaches for HE.
- To outline contemporary management strategies for patients with HE.
Main Methods:
- Literature review of recent studies on hepatic encephalopathy.
- Synthesis of current knowledge on HE pathogenesis.
- Analysis of diagnostic criteria and treatment guidelines.
Main Results:
- Recent developments have shed light on the complex mechanisms underlying HE.
- Improved diagnostic tools are becoming available.
- Effective management strategies can lead to reversible outcomes.
Conclusions:
- Hepatic encephalopathy is a significant complication of liver disease with potential for reversibility.
- Continued research into HE pathophysiology is crucial for advancing diagnosis and treatment.
- A comprehensive approach to diagnosis and management is essential for improving patient outcomes.
Related Concept Videos
Hepatic Encephalopathy
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Disorders of the Nervous Tissue
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Chronic Kidney Disease II: Clinical Manifestations

